A Closer Look at 11 Analyst Recommendations For Crinetics Pharmaceuticals
A Closer Look at 11 Analyst Recommendations For Crinetics Pharmaceuticals
對Crinetics製藥公司的11個分析師建議進行更詳細的分析
An in-depth analysis of recent analyst actions unveils...During the last three months, 11 analysts shared their evaluations of Crinetics Pharmaceuticals (NASDAQ:CRNX), revealing diverse outlooks from bullish to bearish.
在過去的三個月中，有11位分析師共享了他們對Crinetics Pharmaceuticals (NASDAQ:CRNX)的評估，展現了從看好到看淡的不同態度。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級，展示了過去30天內不斷變化的情緒，並將其與前幾個月進行了比較。
Analysts have set 12-month price targets for Crinetics Pharmaceuticals, revealing an average target of $68.64, a high estimate of $97.00, and a low estimate of $54.00. This upward trend is evident, with the current average reflecting a 7.86% increase from the previous average price target of $63.64.
分析師爲Crinetics Pharmaceuticals設定了12個月的目標價，揭示了平均目標價爲68.64美元，最高估價爲97.00美元，最低估價爲54.00美元。這種上升趨勢是明顯的，當前的平均值反映了7.86%的增長，比先前的平均目標價63.64美元高。
Decoding Analyst Ratings: A Detailed Look
分析師評級解讀：詳細解析
An in-depth analysis of recent analyst actions unveils...
最近分析師行動的深...
登入免費觀看全文
登入/註冊